Anil Satwani

Actis to acquire 25% stake in Symbiotec Pharmalab

Actis planned to acquire 25% stake in Symbiotec Pharmalab.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics